Brief: Eloxx Pharmaceuticals Reports Q3 Loss Of 11 Cents Per Share
09/11/2021 13:34
Nov 9 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2021 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* ELOXX PHARMACEUTICALS INC - AS OF SEPTEMBER 30, 2021, WE
HAD
CASH AND CASH EQUIVALENTS OF $52.4 MILLION
* ELOXX PHARMACEUTICALS INC - EXPECT CASH AND CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND OUR OPERATIONS INTO Q1 OF 2023.
* ELOXX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nGNXLJXT1
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome